2004 Meeting Overview:
The Blending Clinical Practice and Research: Forging Partnerships in the Great Lakes Region to Enhance Drug Addiction Treatment Meeting, held on September 27-28, 2004 in Detroit, Michigan, was presented by the National Institute on Drug Abuse (NIDA) and the Great Lakes Regional Node of the Clinical Trials Network (CTN) at Wayne State University, in conjunction with:
- University of Michigan Addiction Research Center and Substance Abuse Section, Department of Psychiatry
- Michigan State University
- Michigan Office of Drug Control Policy, Department of Community Health
- The City of Detroit
- Great Lakes Addiction Technology Transfer Center
- Psychiatry and Behavioral Medicine Professionals
- Gateway Community Health
The conference brought together a variety of professionals and practitioners interested in the field of drug abuse and addiction medicine. It presented a great forum for individuals to discuss and explore current research, both through plenary presentations and interactive workshops.
The format consisted of two plenary presentations, covering the following topics:
- Progress in Translating Drug Abuse Research into Clinical Practice - Nora D. Volkow, Ph.D.
- Disease Management: Addiction as a Chronic Relapsing Disease - Thomas Carli, M.D.
The Eileen Pencer Memorial Lecture was delivered by Lawrence S. Brown, Jr., M.D., M.P.H., FASAM. The goal was to examine the application of science to clinical care, by reviewing what we have learned from current research, considerations for putting research to actual use, and steps for future research in the field.
This year also featured a panel discussion on Issues of Race and Ethnicity in Substance Abuse Treatment, which discussed the challenge of bringing empirically supported interventions to racial/ethnic minority clients in drug abuse treatment practice settings.
Meeting Day 1
|10:15 a.m.||11:45 a.m.||Presentation||Thomas Carli, M.D.|
|11:45 a.m.||12:30 p.m.||Poster Session|
|12:30 p.m.||2:00 p.m.||Afternoon Break|
|2:00 p.m.||4:30 p.m.||Workshops 1-6|
|Methamphetamine: Epidemiology, Neurotoxicity, and Treatment||Charles R. Schuster, Ph.D.
Chris-Ellyn Johanson, Ph.D.
Patricia Marinelli-Casey, Ph.D., MFT
Anna Talamo, M.A., MFT
|Motivational Interviewing: What It Is, How It Works, and How To Make It Work in Your Agency||William R. Miller, Ph.D.
Steven J. Ondersema, Ph.D.
Ned Snead, M.S.
|Buprenorphine: From Basic Human Research to Clinical Application||Mark Greenwald, Ph.D.
Walter Ling, M.D.
Virginia S. Ryan, Ph.D.
Allan J. Cohen, M.A., MFT
|Transitions Across Stages and Levels of Drug Involvement||James C. Anthony, Ph.D., M.Sc.
Richard Spoth, Ph.D.
Thomas Dishion, Ph.D.
Ty A. Ridenour, Ph.D., M.P.E.
|Treatment on Demand: How It Has Affected the Cities of Baltimore, Detroit, Philadephia, and San Francisco||Yvonne E. Anthony, Ph.D., M.B.A., M.H.A.
Calvin R. Trent, Jr., Ph.D., M.Ed.
Joseph Guydish, Ph.D., M.P.H.
Melisa M. Lindamood, M.P.S.
Mark Bencivengo, M.A.
|Addressing Medical and Psychiatric Needs in Substance Abuse Treatment||Michael R. Liepman, M.D.
Jeffrey Selzer, M.D.
John A. Hopper, M.D.
Kathleen A. Sheenan, M.S.N., R.N.
Anne C. Benion, M.S.S., ACSW
Meeting Day 2
|8:30 a.m.||9:45 a.m.||Panel Discussion||Jose Szapocznik, Ph.D.
Daniel A. Santisteban, Ph.D.
R. Dale Walker, M.D.
Lawrence S. Brown, Jr., M.D., M.P.H., FASAM
|9:45 a.m.||10:00 a.m.||Break|
|10:00 a.m.||12:30 p.m.||Workshops 7-12|
|Behavioral Therapies in Substance Abuse Treatment: Contingency Management and Cognitive Behavioral Therapy||Kathleen M. Carroll, Ph.D.
Maxine L. Stitzer, Ph.D.
Gary Rhodes, M.A., LLP
|Co-Occuring Disorders in Substance Abuse Treatment||Kathleen T. Brady, M.D., Ph.D.
Bruce Rounsaville, M.D.
Eric E. Schindler, Ph.D.
|Women and Comorbidity||Cynthia L. Arfken, Ph.D.
Sheryl Pimlott Kubiak, Ph.D., M.S.W.
Shelly F. Greenfield, M.D., M.P.H.
Susan M. Gordon, Ph.D.
Gloria M. Miele, Ph.D.
|Treatment Interventions to Prevent the Next Generation of Substance Abuse: Family-Based Approaches||Robert A. Zucker, Ph.D.
Deborah A. Ellis, Ph.D., M.A.
Karol Kumpfer, Ph.D.
|Evidence-Based Practice: What it Means to the Provider||Joseph Rosenfeld, Psy.D., CRADC
Steven L. Gallon, Ph.D.
Gregory S. Brigham, Ph.D.
|Adjusting Intensity of Substance Abuse Treatment to Patient Need||Robert K. Brooner, Ph.D.
Ron Jackson, M.S.W.
James R. McKay, Ph.D.
|12:30 p.m.||2:00 p.m.||Eileen Pencer Lecture||Lawrence S. Brown, Jr., M.D., M.P.H., FASAM|
|2:00 p.m.||Blending Conference Adjournment|
|2:00 p.m.||5:00 p.m.||Mini-Courses|
|An Introduction to Motivational Interviewing||Steven J. Ondersma, Ph.D.|
|Buprenorphine for the Treatment Team||Susan M. Stine, M.D., Ph.D.
Laura F. McNicholas, M.D., Ph.D.
Albert L. Hasson, M.S.W.
|Issues Related to HIV and Hepatitis C in Substance Abuse||John A. Hopper, M.D.
Jeffrey Samet, M.D., M.A., M.P.H.
|Best Practice in Addiction Treatment: How to Improve Skills as a Consumer of Research||Lonnetta Albright
Steven L. Gallon, Ph.D.
Joseph Rosenfeld, Psy.D., CRADC
Wendy Hausotter, M.P.H.